EP2522354

Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    12.5.2011
  • EP published:
    23.8.2017
  • EP application number:
    11165869.6
  • Max expiry date:
    11.5.2031
  • Title:
    Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins

Timeline

Today
12.5.2011EP application
23.8.2017EP Publication

Owner

  • Name:
    CSL Behring GmbH
  • Address:
    Emil-von-Behring-Strasse 76, 35041, Marburg, DE

Inventor

  • Name:
    Schulte, Stefan
  • Address:
    Marburg, DE
  • Name:
    Kalina, Uwe
  • Address:
    Marburg, DE
  • Name:
    Moses, Michael
  • Address:
    Grävenwiesbach, DE
  • Name:
    Feussner, Annette
  • Address:
    Marburg, DE

Classification

  • Categories:
    A61K 31/727, A61K 35/16, A61K 38/57, A61P 7/02, A61P 1/00, A61P 11/08, A61P 9/06, A61P 9/12

Upload documents